Key points are not available for this paper at this time.
Our prospective, multi-institutional study demonstrated low rates of neurologic death when SRS/SRT as opposed to WBRT is used in patients with SCLC and 1-10 brain metastases who are surveilled closely post-treatment, supporting the utility of stereotactic approaches in this population.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ayal A. Aizer
Shyam Tanguturi
Diana D. Shi
Journal of Clinical Oncology
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Aizer et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d807a4a2a48916bbbee9ee — DOI: https://doi.org/10.1200/jco-25-00056